EVELO BIOSCIENCES INC's ticker is EVLO and the CUSIP is 299734103. A total of 43 filers reported holding EVELO BIOSCIENCES INC in Q3 2019. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $11,000 | -45.0% | 3,264 | 0.0% | 0.00% | – |
| Q4 2021 | $20,000 | -13.0% | 3,264 | +1.6% | 0.00% | – |
| Q3 2021 | $23,000 | -47.7% | 3,213 | 0.0% | 0.00% | – |
| Q2 2021 | $44,000 | +63.0% | 3,213 | +27.6% | 0.00% | – |
| Q1 2021 | $27,000 | 0.0% | 2,518 | +11.2% | 0.00% | – |
| Q4 2020 | $27,000 | +92.9% | 2,264 | -15.4% | 0.00% | – |
| Q3 2020 | $14,000 | +55.6% | 2,677 | +38.8% | 0.00% | – |
| Q2 2020 | $9,000 | +50.0% | 1,929 | +26.7% | 0.00% | – |
| Q1 2020 | $6,000 | -33.3% | 1,522 | -32.1% | 0.00% | – |
| Q4 2019 | $9,000 | -30.8% | 2,242 | +4.7% | 0.00% | – |
| Q3 2019 | $13,000 | -31.6% | 2,142 | 0.0% | 0.00% | – |
| Q2 2019 | $19,000 | +11.8% | 2,142 | 0.0% | 0.00% | – |
| Q1 2019 | $17,000 | -39.3% | 2,142 | 0.0% | 0.00% | – |
| Q4 2018 | $28,000 | +180.0% | 2,142 | +169.8% | 0.00% | – |
| Q3 2018 | $10,000 | +11.1% | 794 | 0.0% | 0.00% | – |
| Q2 2018 | $9,000 | – | 794 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Mayo Clinic | 484,953 | $1,823,000 | 4.61% |
| Flagship Pioneering Inc. | 18,233,403 | $68,558,000 | 3.21% |
| HARBOURVEST PARTNERS LLC | 1,763,505 | $6,622,000 | 3.20% |
| Alphabet Inc. | 1,060,495 | $3,982,000 | 0.26% |
| Larson Financial Group LLC | 20,042 | $75,000 | 0.05% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 133,500 | $501,000 | 0.01% |
| CREDIT SUISSE AG/ | 1,500,117 | $5,633,000 | 0.01% |
| FMR LLC | 3,220,853 | $12,094,000 | 0.00% |
| VICTORY CAPITAL MANAGEMENT INC | 177,856 | $668,000 | 0.00% |
| Legal & General Group Plc | 1,522 | $6,000 | 0.00% |